kpi-121
kala pharmaceuticals,abbvie
['ibd', 'stride ii', 'abbvie']
goals in #ibd care are evolving beyond managing symptoms to include mucosal healing. stride ii recommends mucosal healing as an important treatment target. #uegweek 
AbbVie's global handle featuring biopharmaceutical news & updates managed by our corp digital team. Review our guidelines: https://t.co/oWTsp1VCTN